FFRangio System vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

FFRangio System

by CathWorks (acquired by Medtronic)

VX1

by Volta Medical

AI Verdict

The FFRangio System is tailored for interventional cardiologists, providing AI-driven FFR guidance to optimize PCI decisions for coronary artery disease. In contrast, the VX1 assists cardiac electrophysiologists by using AI to identify dispersed electrograms during atrial fibrillation and tachycardia ablation procedures. While both are AI tools for interventional cardiology, they address distinct cardiac pathologies and support different sub-specialties and procedural types.

Choose FFRangio System if…

Choose the FFRangio System if you need a comprehensive, non-invasive physiological assessment of coronary artery disease to optimize percutaneous coronary intervention (PCI) decisions. This system is ideal for quickly obtaining multi-vessel FFR results and advanced insights like simulated pullback and lesion impact, all without the use of invasive pressure wires or vasoactive drugs.

View FFRangio System →

Choose VX1 if…

Choose VX1 if you are a cardiac electrophysiologist seeking real-time, AI-guided assistance to identify dispersed electrograms during atrial fibrillation or atrial tachycardia ablation procedures. This tool is best suited for standardizing ablation targets and reducing inter-operator variability, thereby enhancing the precision and potential efficacy of complex arrhythmia treatments.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	FFRangio System	VX1
Pricing	Contact vendor for pricing information.	Contact for pricing
Deployment	SaaS, on-prem, hybrid	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	FFRangio System	VX1
Name	FFRangio System	VX1
Company	CathWorks	Volta Medical
Description	The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease.	Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Tagline	A New Era in Coronary Physiology	Transforming EP Data into AI Solutions
Categories	Cardiology AI, Surgical AI	Cardiology AI, Surgical AI
Specialties	Cardiology	Cardiology
Key Features (partial)	Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia	AI-guided real-time identification of dispersed electrograms (EGMs), Assists cardiologists during AFib and atrial tachycardia ablation procedures, Analyzes 3D anatomical and electrical maps of human atria

Videos

Demos, reviews, and walkthroughs featuring FFRangio System and VX1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions and procedures are addressed by the FFRangio System versus the VX1?

The CathWorks FFRangio System provides wire-free and drug-free 3D FFR guidance to optimize and confirm PCI decisions for patients with coronary artery disease. In contrast, Volta Medical's VX1 is an AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.

How do these AI tools integrate with existing equipment in the cardiac catheterization lab or electrophysiology lab?

The FFRangio System is deployed on-premise and integrates with cath lab equipment and C-arm angiography systems. The VX1 is software integrated with existing electrophysiology (EP) lab mapping and recording systems and is compatible with most EP recording, 3D navigation systems, and mapping catheters.

What type of data does each system analyze to provide its AI-driven insights?

The FFRangio System uses artificial intelligence to aid in quick angiogram analysis and provides real-time FFRangio values at every point on the coronary tree. The VX1 analyzes 3D anatomical and electrical maps of human atria and electrograms to identify dispersed electrograms.

Does either system reduce the need for invasive tools or procedures?

The FFRangio System eliminates the need for invasive pressure wires, drugs, or a guide catheter for FFR assessment. The VX1 assists cardiologists during AFib and atrial tachycardia ablation procedures by providing AI-guided real-time identification of dispersed electrograms.

What are the primary clinical goals each tool aims to achieve for patient care?

The FFRangio System aims to optimize and confirm PCI decisions for patients with coronary artery disease by providing accurate multi-vessel FFR results and advanced insights. The VX1 is designed to assist cardiologists during AFib and atrial tachycardia ablation procedures to reduce inter-operator variability and standardize outcomes.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform